| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
277,430,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sotera Health is a holding company. Through its subsidiaries, Co. provides sterilization, lab testing and advisory services for the healthcare industry with operations primarily in the Americas, Europe and Asia. Co.'s segments are: Sterigenics, which provide outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and applications markets using three main technologies: gamma irradiation, ethylene oxide processing and E-beam irradiation; Nordion, which provides Cobalt-60 used in the sterilization and irradiation processes; and Nelson Labs, which provides outsourced microbiological and analytical chemistry testing and advisory services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
45,344,363 |
45,344,363 |
45,344,363 |
45,344,363 |
| Total Sell Value |
$648,764,474 |
$648,764,474 |
$648,764,474 |
$648,764,474 |
| Total People Sold |
6 |
6 |
6 |
6 |
| Total Sell Transactions |
6 |
6 |
6 |
6 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lyons Jonathan M. |
Sr. Vice President, CFO |
• – – |
2024-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
41,124 |
118,091 |
|
- |
|
| Warburg Pincus Partners Ii, L.p. |
Director |
– • • |
2024-03-04 |
4 |
S |
$14.31 |
$237,423,849 |
I/I |
(16,594,363) |
88,822,952 |
|
- |
|
| Warburg Pincus Partners Gp Llc |
Director |
– • • |
2024-03-04 |
4 |
S |
$14.31 |
$237,423,849 |
I/I |
(16,594,363) |
88,822,952 |
|
- |
|
| Dimitrief Alexander |
SVP, General Counsel and Sec. |
• – – |
2024-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
51,405 |
286,883 |
|
- |
|
| Gtcr Partners Xi/a&c Lp |
Director |
– • • |
2024-03-04 |
4 |
S |
$14.31 |
$158,282,556 |
I/I |
(11,062,908) |
59,215,301 |
|
- |
|
| Klee Ann R. |
|
– • – |
2024-03-04 |
4 |
S |
$14.31 |
$82,268 |
D/D |
(5,750) |
86,735 |
|
- |
|
| Petras Michael B. Jr. |
Chairman & CEO |
• – – |
2024-03-04 |
4 |
S |
$14.31 |
$14,362,870 |
I/I |
(1,003,870) |
5,453,580 |
|
- |
|
| Petras Michael B. Jr. |
Chairman & CEO |
• – – |
2024-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
274,160 |
699,749 |
|
- |
|
| Rutz Michael P |
President of Sterigenics |
• – – |
2024-03-04 |
4 |
S |
$14.31 |
$1,189,082 |
D/D |
(83,109) |
544,409 |
|
- |
|
| Rutz Michael P |
President of Sterigenics |
• – – |
2024-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
34,270 |
627,518 |
|
- |
|
| Petras Michael B. Jr. |
Chairman & CEO |
• – – |
2024-03-02 |
4 |
D |
$14.56 |
$721,652 |
D/D |
(49,564) |
425,589 |
|
- |
|
| Rutz Michael P |
President of Sterigenics |
• – – |
2024-03-02 |
4 |
D |
$14.56 |
$80,095 |
D/D |
(5,501) |
593,248 |
|
- |
|
| Rutz Michael P |
President of Sterigenics |
• – – |
2023-11-20 |
4 |
D |
$13.93 |
$26,620 |
D/D |
(1,911) |
598,749 |
|
- |
|
| Petras Michael B. Jr. |
Chairman & CEO |
• • – |
2023-11-20 |
4 |
D |
$13.93 |
$407,453 |
D/D |
(29,250) |
555,418 |
|
- |
|
| Lyons Jonathan M. |
Sr. Vice President, CFO |
• – – |
2023-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
76,967 |
76,967 |
|
- |
|
| Donnini David |
Director |
– • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,712 |
41,560 |
|
- |
|
| Neary James |
Director |
– • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,712 |
41,560 |
|
- |
|
| Petrella Vincent K |
Director |
– • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,712 |
41,560 |
|
- |
|
| Knauss Robert Brown |
Director |
– • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,712 |
15,712 |
|
- |
|
| Klee Ann R. |
Director |
– • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,712 |
92,485 |
|
- |
|
| Chen Ruoxi |
Director |
– • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,712 |
41,560 |
|
- |
|
| Cunningham Sean Laurence |
Director |
– • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,712 |
41,560 |
|
- |
|
| Mihas Constantine S |
Director |
– • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,712 |
41,560 |
|
- |
|
| Wheadon David E. |
Director |
– • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,712 |
35,691 |
|
- |
|
| Rutz Michael P |
President of Sterigenics |
• – – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
28,425 |
600,660 |
|
- |
|
85 Records found
|
|
Page 1 of 4 |
|
|
